Please wait...



Business Plan 2016-2020


Α. Neurosurgery & Neurology BU 2016 2017 2018 2019 2020
Domestic Sales 1.147.500,00 1.262.250,00 1.388.475,00 1.527.322,50 1.680.054,75
Foreign Sales 1.402.500,00 1.550.250,00 1.718.400,00 1.909.833,75 2.127.849,94
Total Sales (1) 2.550.000,00 2.812.500,00 3.106.875,00 3.437.156,25 3.807.904,69
B. Cardiology & Surgery BU 2016 2017 2018 2019 2020
Domestic Sales 125.000,00 137.500,00 151.250,00 166.375,00 183.012,50
Foreign Sales 25.000,00 162.500,00 208.750,00 265.625,00 335.387,50
Total Sales (2) 250.000,00 300.000,00 360.000,00 432.000,00 518.400,00
C. Orthopedics BU 2016 2017 2018 2019 2020
Domestic Sales 120.000,00 132.000,00 145.200,00 159.720,00 175.692,00
Foreign Sales 80.000,00 108.000,00 142.800,00 185.880,00 239.028,00
Total Sales (3) 200.000,00 240.000,00 288.000,00 345.600,00 414.720,00
Total Sales (1+2+3) 3.000.000,00 3.352.500,00 3.754.875,00 4.214.756,25 4.741.024,69
(figures in ‘000s €)

Assumptions

1. The Cardiology-Surgery BU is a new segment which we are currently negotiating to enter through a partnership with an established Greek importer and distributor.
2. Domestic sales are projected to grow by an annual 10% rate in period 2015-2019
3. Sales to export markets are projected to grow by 25% in 2017 and thereafter by 20% p.a.
4. The Public Sector will absorb 75% of sales in Greece and the Private Sector for 25%.
5. In foreign countries the 80% of sales will be directed to private dealers and the rest to public organizations.
6. Target export markets: Romania, Bulgaria, Fyrom, Cyprus, Moldavia, Serbia, kazakhstan.

Copyright ©2014-2017 Neuraxon Ltd - All Rights Reserved